A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53 -mutant Ovarian Cancer

Oza, Amit M., Estevez-Diz, Maria, Grischke, Eva-Maria · Clinical Cancer Research · 2020